A possible explanation for differing Δ133p53 levels in cancer specimens observed in the present study might be provided by the presence of several polymorphisms within the internal promoter region located in the intron 4 of the p53 gene, which gives rise to Δ133p53 (Bellini et al, 2010). This evidence concerns the gene TP53 and cancer.